Danny McAuley

Danny McAuley is a Clinical Professor at Queen's University Belfast's School of Medicine, Dentistry and Biomedical Sciences and Consultant in Intensive Care Medicine at the Royal Victoria Hospital. His research strategy focuses on novel therapeutic development for Acute Respiratory Distress Syndrome (ARDS), progressing from in vitro studies to phase 2 clinical trials.

Research examines statins, extracorporeal CO2 removal, mesenchymal stem cells, and antimicrobial peptides for ARDS treatment. Additional interests include sepsis diagnostics, critical illness delirium, and recovery interventions. Leads multiple clinical trials on mucoactive drugs, sedation protocols, and biomarker-guided sepsis therapy.

Publications span ARDS management guidelines, COVID-19 host responses, pulmonary fibrosis, and ventilation strategies. Recent work emphasizes pandemic-related critical care, genetic mechanisms of severe COVID-19, and respiratory outcome standardization.

Active in PhD supervision and national/international research networks including UK Intensive Care Society and NICRN Critical Care clinical lead. Research impacts critical care protocols globally through clinical guidelines and trial design.